Utama › Penyakit Paru-paru › Tennessee › Nashville
Kajian klinikal Penyakit Paru-paru di Nashville, TN
10 kajian untuk Penyakit Paru-paru sedang mencari peserta di lokasi dalam dan sekitar Nashville (dalam lingkungan kira-kira 30 batu). Buka kajian untuk melihat siapa yang layak menyertai dan cara menghubungi pasukan kajian.
Teks kajian rasmi (Bahasa Inggeris)
Mengambil peserta untuk kajian di sini? Paparkan di bahagian atas halaman ini — $99 selama 30 hari →
Neladalkib (NVL-655) for TKI-naive Patients With Advanced ALK-Positive NSCLC
Mengambil pesertaFasa 3
- SCRI Oncology Partners, Nashville
American Lung Association (ALA) Lung Health Cohort
Mengambil pesertaKajian pemerhatianSukarelawan sihat dialu-alukan
- Vanderbilt University Medical Center, Nashville
Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
Mengambil pesertaFasa 1/2
- Sarah Cannon Research Institue, Nashville
A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate-To-Severe Asthma
Mengambil pesertaFasa 2
- Premier Research Center, LLC, Hendersonville · 13 mi jauh
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
Mengambil pesertaFasa 3
- Tennessee Oncology, Nashville
- USO - US Oncology Research Network, Nashville
Clinical Trial of Omalizumab for Allergen Sensitized and Exposed Individuals With COPD
Mengambil pesertaFasa 2
- Vanderbilt University Medical Center, Nashville
Trial to Evaluate the Efficacy and Safety of LYT-100 (Deupirfenidone) Compared to Pirfenidone in Adults With Idiopathic Pulmonary Fibrosis (IPF)
Mengambil pesertaFasa 3
- Clinical Trials Center of Middle Tennesee LLC, Franklin · 17 mi jauh
A Study of Zipalertinib in Patients With Advanced Non-Small Cell Lung Cancer With Epidermal Growth Factor Receptor (EGFR) Exon 20 Insertions or Other Uncommon Mutation.
Mengambil pesertaFasa 2
- SCRI Oncology Partners, Nashville
Cooperative Assessment of Late Effects for SCD Curative Therapies
Mengambil pesertaKajian pemerhatian
- Vanderbilt University Medical Center, Nashville
A Study to Evaluate Vimseltinib in Adults With Active Chronic Graft-Versus-Host Disease (cGVHD)
Mengambil pesertaFasa 2
- Tristar Bone Marrow Transplant, Nashville
- Vanderbilt-Ingram Cancer Center, Nashville
Kajian Penyakit Paru-paru di bandar lain
- Houston, TX15 kajian
- Boston, MA14 kajian
- Durham, NC13 kajian
- New York City, NY12 kajian
- Pittsburgh, PA11 kajian
- Los Angeles, CA10 kajian
- Columbus, OH10 kajian
- Dallas, TX10 kajian
- Washington, DC10 kajian
- Miami, FL10 kajian
- Ann Arbor, MI10 kajian
- Chicago, IL9 kajian
Kajian lain di Nashville
- Kanser Paru-paru Bukan Sel Kecil97 kajian
- Kanser Payudara80 kajian
- Kanser Metastatik70 kajian
- Kanser Kolorektal69 kajian
- Kanser (semua jenis)65 kajian
- Kanser Ovari49 kajian
- Kanser Prostat42 kajian
- Kanser Paru-paru40 kajian
- Karsinoma Sel Skuamosa Kepala dan Leher39 kajian
- Kanser Pankreas39 kajian
- Kanser Endometrium38 kajian
- Melanoma33 kajian
Daripada ClinicalTrials.gov, data diperoleh pada 5 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.